“Subcutaneous Administration of Tocilizumab Is Effective in Myointimal Hyperplasia Remodelling in Refractory Takayasu Arteritis”. Reumatismo 69, no. 4 (December 21, 2017): 184–188. Accessed April 26, 2025. https://www.reumatismo.org/reuma/article/view/1013.